Please login to the form below

Not currently logged in
Email:
Password:

Protein Sciences

This page shows the latest Protein Sciences news and features for those working in and with pharma, biotech and healthcare.

Sanofi to pay $750m for vaccines biotech Protein Sciences

Sanofi to pay $750m for vaccines biotech Protein Sciences

Sanofi to pay $750m for vaccines biotech Protein Sciences. Adds US firm's recombinant-based influenza vaccine to its portfolio. ... Sanofi is to acquire Protein Sciences in a deal that could be worth up to $750m for the Connecticut, US-based biotech

Latest news

  • Budget deal brings FDA back to life Budget deal brings FDA back to life

    Advisory committee meetings continued and there were a few new product approvals and alerts, although there are reports of delays for some products including a flu vaccine made by Protein Sciences.

  • FDA approves first egg-free flu vaccine Flublok FDA approves first egg-free flu vaccine Flublok

    production. Instead, the vaccine, which was developed by Protein Sciences in partnership with the US Department of Health and Human Services, is produced using an insect virus (baculovirus). ... Protein Sciences is also developing Panblok in partnership

  • Early identification key for healthcare

    The meeting also heard about the growing antibodies market. Lotta Ljungqvist, head of R&D BioTechnologies, Life Sciences at GE Healthcare Sweden, said: "There will be more protein-based drugs available ... The region has already attracted AstraZeneca, GE

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2015 Deal Watch October 2015

    Regaining of rights. 564. Alpine Immune Sciences/ Kite Pharma. 2 transmembrane immunomodulatory protein (TIP) programmes (discovery). ... Collaboration - R&D. 126. †† Genexine/ Tasgen Bio-Tech. 3 clinical and 2 preclinical therapeutic protein/

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    172. Nerviano Medical Sciences / Servier . Collaboration, licence, option. Protein kinase TTK/MPS1 inhibitors (preclinical).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • F-star appoints vice president of protein sciences F-star appoints vice president of protein sciences

    F-star appoints vice president of protein sciences. Mike Davies joins from CPI Biologics. ... Vienna-headquartered biopharmaceutical company F-star has appointed Mike Davies as vice president of protein sciences at its Cambridge, UK research site.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics